Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the price of this innovative drug and its availability have become key concerns for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its costly nature presents a significant challenge